CorMedix Inc.
CRMD | NASDAQ
$7.77
+$0.05 (+0.65%)
At close: Sep 21, 2026, 4:00 PM ET
$7.77
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $605.65M
Enterprise Value $498.03M
Beta 1.50
Average Volume 1.3M
Shares Outstanding (Diluted) 92.48M
Shares Change YoY 28.59%
Institutional Ownership 51.78%
Exchange NASDAQ
ISIN US21900C3088
Price Performance
Price Change 1M -5.7%
Price Change 3M -9.7%
Price Change 6M 17.6%
Price Change YTD -36.1%
Price Change 1Y -31.1%
Price Change 3Y 111.7%
Price Change 5Y 66.7%
1M CAGR (ann.) 2.8%
1Y CAGR (ann.) -30.6%
5Y CAGR (ann.) 10.8%
All-Time CAGR -4.0%
Valuation
PE Ratio 3.65
Forward PE 125.07
PEG Ratio 0.02
Forward PEG -0.04
PS Ratio 1.32
Forward PS 2.10
PB Ratio 1.32
P/FCF Ratio 2.42
P/Adj. FCF Ratio 2.50
P/OCF Ratio 2.40
EV/Sales 1.08
EV/EBIT 2.32
EV/EBITDA 2.00
EV/FCF 1.98
Earnings Yield 27.4%
FCF Yield 41.3%
Adj. FCF Yield 40.0%
Financial Health
Net Cash $111.54M
Total Debt $145.15M
Cash & Short-Term Investments $256.69M
Total Assets $904.05M
Current Ratio 2.56
Quick Ratio 2.36
Debt / Equity Ratio 0.31
Debt / EBITDA 0.58
Debt / FCF 0.58
OCF / Debt 1.75
Interest Coverage 78.49
Altman Z-Score 2.33
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 82.8%
Operating Profit Margin 47.0%
EBITDA Margin 54.0%
Net Profit Margin 40.5%
FCF Margin 54.5%
Adj. FCF Margin 52.8%
SBC / Revenue 1.7%
SBC Impact (per share) -3.0%
Returns
Return on Assets 20.7%
Return on Equity 44.6%
Return on Invested Capital 27.9%
Return on Capital Employed 30.3%
Return on Tangible Assets 36.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 2230.5%
Revenue CAGR 5Y 351.9%
Revenue CAGR 10Y 128.9%
EPS CAGR 3Y 235.4%
EPS CAGR 5Y 1160.9%
EPS CAGR 10Y 54.9%
FCF CAGR 3Y 196.8%
FCF CAGR 5Y 176.2%
FCF CAGR 10Y 264.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 8
EPS Growth Next 3Y -25.9%
Revenue Growth Next 3Y -1.9%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number $16.77
Graham Upside 115.8%
Lynch Fair Value $53.25
Lynch Upside 585.3%
Price Target $14
Price Target Upside 80.2%
Cash Flow
Operating Cash Flow $253.94M
Free Cash Flow $251.71M
Adj. Free Cash Flow $244.06M
FCF Per Share $3.21
OCF Per Share $3.24
OCF/S Ratio 54.9%
Income Statement
Revenue $462.25M
Gross Profit $382.64M
Operating Income $217.04M
EBITDA $249.59M
Net Income $187.17M
EPS (Diluted) $2.13
Revenue / Employee $2.42M
Profit / Employee $979.96K
Employees 191
Add to Watchlist
Select watchlists to add or remove CRMD